David Jackson, PhD.

Chief Executive Officer, Board Director, Co-Founder

David is the Chief Executive Officer of Site Intelligence. He has over 25 years experience in the IT sector, most recently as a senior executive of Oxford Molecular Group plc, a major international supplier of advanced IT systems for Pharmaceutical Research. 

David played a major role in taking OMG public on London’s main market in 1994 and was instrumental in driving the company’s aggressive growth in the US through both organic development and strategic acquisition.  David was appointed Chief Operating Officer and main board director in 1996 and took the company to £21M Revenue and 220 employees by the end of 1998. 

In 2000 David became the Executive Chairman of an MBO team which purchased the Fraser Williams software group, the world’s leading supplier of clinical trials management software. The company was subsequently sold to Parexel in 2002.  He was also the founder of Screen Science Ltd, a multi-media development company which was sold to the Adval Group plc in 1999.  After co-founding Site Intelligence in 2000, David became CEO in December 2002.

David is currently a visiting Professor of Marketing Analytics at Southampton University